Abstract: A housing for a laser processing machine is described to treat work pieces. The housing comprises a dividing wall, which separates a first work space having a first length and a second work space having a second length from one another, a first entrance to allow access to the first work space, a second entrance to allow access to the second work space, a closing device, which is configured to selectively open and close the first entrance and the second entrance and a control unit, which is operatively connected to the closing device. The dividing wall is placeable in an operating position, which is variable among at least a first position, a second position and a third position. The control unit is configured to control the closing device as a function of the operating position of the dividing wall.

Abstract: A housing for a laser processing machine is described comprising a dividing wall, which separates a first work space and a second work space, and a covering device, which is configured to selectively cover at least one between the first work space and the second work space. The covering device comprises at least a cover, which is controllable in an active configuration, in which the cover is configured to cover one between the first work space and the second work space and a guide system, which is configured to guide the cover so that the cover, when it is in the active configuration, comprises at least a main portion and an auxiliary portion extending from the main portion and being inclined relative to the main portion.

Abstract: The present disclosure relates to solid state forms of Pemafibrate processes for preparation thereof and pharmaceutical compositions thereof.

Abstract: The present disclosure relates to solid state forms of Pemafibrate processes for preparation thereof and pharmaceutical compositions thereof.

Abstract: Apparatus and method for recovering precious metals from contaminated cement, comprising, in order of process, a crusher, in which a cement-metal conglomerate is placed, a sieve, a dispenser, a first container, suitable for collecting the metal on the bottom through the action of a magnetic stirrer, an expander, a second container, a drainage tank, and a sieve. The present invention relates in particular to the recovery of precious metal from the batch of cement contaminated by precious metals, such as platinum, rhodium, gold, or silver. In the production of glass fibers for reinforcement, dies made of an alloy of precious metals, in particular platinum and rhodium, are used. These dies are supported by a special cement structure. During the months of production life of the die, part of the precious metal diffuses into the cement on account of the high temperatures. Given the value of the metals, it is economically advantageous to recover them from the supporting cement at each change of the die.

Abstract: The present disclosure relates to solid state forms of Pemafibrate processes for preparation thereof and pharmaceutical compositions thereof.

Abstract: The present invention relates to a polymer composition comprising at least one block copolymer and a specific amount of at least one oil component. The block copolymer, which is the polymeric matrix of the inventive composition, is built up from at least one vinyl aromatic monomer MA and at least one conjugated diene monomer MB, in particular the block copolymer is a styrene butadiene block copolymer (SBC).

Abstract: The present invention relates to a polymer composition comprising at least one block copolymer and a specific amount of at least one oil component. The block copolymer, which is the polymeric matrix of the inventive composition, is built up from at least one vinyl aromatic monomer MA and at least one conjugated diene monomer MB, in particular the block copolymer is a styrene butadiene block copolymer (SBC).

Abstract: Polymer blend comprising components A, B and C: A: 1 to 19.5% by weight of an elastomeric block copolymer A based on styrene (S-TPE); B: 0.5 to 8% by weight of a compatibilizer component B; and C: 80 to 98.5% by weight of at least one semi-crystalline olefin homo- or copolymer C. The invention further relates to a composition comprising thermoplastic elastomers based on styrene (S-TPE) for use as compatibilizer of S-TPE block copolymers and polyolefins, a process for the preparation of the polymer blend, a master batch for the preparation of the polymer blend, and single- and multilayer films comprising said polymer blend and their use for food packaging and as shrink hood.

Abstract: Polymer blend comprising components A, B and C: A: 1 to 19.5% by weight of an elastomeric block copolymer A based on styrene (S-TPE); B: 0.5 to 8% by weight of a compatibilizer component B; and C: 80 to 98.5% by weight of at least one semi-crystalline olefin homo- or copolymer C. The invention further relates to a composition comprising thermoplastic elastomers based on styrene (S-TPE) for use as compatibilizer of S-TPE block copolymers and polyolefins, a process for the preparation of the polymer blend, a master batch for the preparation of the polymer blend, and single- and multilayer films comprising said polymer blend and their use for food packaging and as shrink hood.

Abstract: Elastomeric block copolymers having star-shaped molecular architecture, where the star-shaped molecular architecture has at least two different arms of the star, a process for producing the elastomeric block copolymers, the use of the elastomeric block copolymers for producing moldings, or as adhesive layer in multilayer foils; as seal; as adhesion promoter or thermoplastic component in wood-plastics composites; as hot-melt adhesive component; for impact-modifying thermoplastics or elastomers, or for compatibilization, and to foils, foams, thermomoldings, injection moldings, flexible tubing, or profile extrudates composed of at least one elastomeric block copolymer.

Abstract: New histone deacetylase inhibitors according to the general formula (I) wherein: Q is a bond, CH2, CH—NR3R4, NR5 or oxygen, X is CH or nitrogen, Y is a bond, CH2, oxygen or NR6, Z is CH or nitrogen, R1, R2 are, independently, hydrogen, halogen, C1-C6 alkyl or C1-C6 haloalkyl, R11, R12 are, independently, hydrogen or C1-C6 alkyl, and R3, R4, R5 and R6 are as further defined in the specification.

Abstract: This invention is related to new histone deacetylase inhibitors according to the general formula (I) wherein: Q is a bond, CH2, NR5 or oxygen, X is CH or nitrogen, Y is a bond, CH2, oxygen or NR6, Z is CH or nitrogen, R1, R2 are, independently, hydrogen or C1-C6 alkyl, R3, R4 are, independently, hydrogen, halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl or C1-C6 haloalkoxy, and R5 and R6 are as further defined in the specification, and pharmaceutical acceptable salts thereof.

Abstract: This invention is related to new histone deacetylase inhibitors according to the general formula (I) wherein: the dotted line is an optional additional bond; R1 is hydrogen, halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl or C1 C6 haloalkoxy; R2, R3 are, independently, hydrogen; C1-C6 alkyl; aryl; or taken together with the carbon atoms to which they are bound form a bridged bicyclic ring or a fused heterocycle; X is CH or nitrogen; Y is a bond, oxygen, (CH2)mCR4R5(CH2)n, or (CH2)oNR6(CH2)p; m, n, o, p, R4, R5 and R6 are as further defined in the specification; and pharmaceutical acceptable salts thereof.

Abstract: New histone deacetylase inhibitors according to the general formula (I) wherein: Q is a bond, CH2, CH—NR3R4, NR5 or oxygen, X is CH or nitrogen, Y is a bond, CH2, oxygen or NR6, Z is CH or nitrogen, R1, R2 are, independently, hydrogen, halogen, C1-C6 alkyl or C1-C6 haloalkyl, R11, R12 are, independently, hydrogen or C1-C6 alkyl, and R3, R4, R5 and R6 are as further defined in the specification.

Abstract: This invention is related to new histone deacetylase inhibitors according to the general formula (I) wherein: Q is a bond, CH2, NR5 or oxygen, X is CH or nitrogen, Y is a bond, CH2, oxygen or NR6, Z is CH or nitrogen, R1, R2 are, independently, hydrogen or C1-C6 alkyl, R3, R4 are, independently, hydrogen, halogen, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 haloalkyl or C1-C6 haloalkoxy, and R5 and R6 are as further defined in the specification, and pharmaceutical acceptable salts thereof.

Abstract: New histone deacetylase inhibitors according to the general formula (I) wherein: Q is a bond, CH2, CH—NR3R4, NR5 or oxygen, X is CH or nitrogen, Y is a bond, CH2, oxygen or NR6, Z is CH or nitrogen, R1, R2 are, independently, hydrogen, halogen, C1-C6 alkyl or C1-C6 haloalkyl, R11, R12 are, independently, hydrogen or C1-C6 alkyl, and R3, R4, R5 and R6 are as further defined in the specification.